<DOC>
	<DOCNO>NCT02823353</DOCNO>
	<brief_summary>Ursodeoxycholic acid ( UDCA ) treatment primary biliary cirrhosis ( PBC ) approve US European drug administration . Long-term use UDCA ( 13â€”15 mg/kg/day ) patient PBC improve serum liver biochemistry survival free liver transplantation However , 40 % patient respond UDCA optimally assess know criterion biochemical response . Those patient represent group need additional therapy , increase risk disease progression decrease survival free liver transplantation . Both lab research clinical study suggest fenofibrate could improve cholestasis multiple way include reduce bile acid synthesis , increase biliary secretion anti-inflammation effect . Here start random , open parallel clinical research explore effect fenofibrate PBC treatment .</brief_summary>
	<brief_title>Fenofibrate Combination With Ursodeoxycholic Acid Primary Biliary Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Cirrhosis , Biliary</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>1 . Signed informed consent 2 . Patient PBC define 2 3 follow criterion : a.Positive antimitochondrial antibody type M2 ; b.Abnormal serum alkaline phosphatase ( ALP &gt; 1,5N ) aminotransferase ( AST/ALT &gt; 1N ) activity ; c.Histological hepatic injury consistent PBC . 1 . Pregnancy desire pregnancy . 2 . Breastfeeding . 3 . Coexisting liver disease acute chronic viral hepatitis , alcoholic liver disease , choledocholithiasis , autoimmune hepatitis , biopsyproven nonalcoholic fatty liver disease , Wilson 's disease hemochromatosis 4 . History presence hepatic decompensation ( e.g. , variceal bleeds , encephalopathy , poorly control ascites ) . 5 . History urolithiasis , nephritis renal failure ( clearance creatinine &lt; 60 ml/mn ) . 6 . Hepatotoxic drug use recruiting . 7 . Fenofibrate anaphylaxis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>PBC</keyword>
	<keyword>UDCA</keyword>
	<keyword>Fenofibrate</keyword>
</DOC>